Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Melanotan 2 peptide nasal spray (MT2) is a synthetic analogue of the naturally occurring alpha-melanocyte-stimulating hormone (-MSH) used primarily in clinical laboratory studies
As of 2024, there is no established clinical connection between GLP-1 receptor agonists and endometriosis treatment
It supports both physical and cognitive performance by improving energy efficiency in the body
Increased energy may also promote greater physical activity, which can be an important part of your overall wellness and weight management journey